anti-FLT4 antibody product blog
Tags: Antibody; Polyclonal Antibody; FLT4; anti-FLT4 antibody;
The FLT4 flt4 (Catalog #MBS611064) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Flt4 (Fms-like Tyrosine Kinase 4) reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s Flt4 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC).Suitable for use in Western Blot, Immunoprecipitation and Immunohistochemistry.
Dilution: Immunohistochemistry (Formalin/paraffin): 1:100 for 30 minutes. Staining of formalin-fixed tissues requires boiling tissue sections in 10mM citrate buffer, pH 6.0 for 10-20 min followed by cooling at RT for 20 min. Researchers should empirically determine the suitability of the FLT4 flt4 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The FLT4 flt4 product has the following accession number(s) (GI #1150991) (Uniprot Accession #P35916). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Flt4 (Fms-like Tyrosine Kinase 4) with the following immunoassay(s):
Testing Data (Human placenta stained with MBS611064.)
Three cell membrane receptor tyrosine kinases, Flt (also designated VEGF-R1), Flk-1 (also designated VEGF-R2) and Flt-4 (also designated VEGF-R3), putatively involved in the growth of endothelial cells, are characterized by the presence of seven immunoglobulin-like sequences in their extracellular domain. On the basis of structural similarity to Flt and Flk-1, it has been speculated that Flt-4 might represent a third receptor for either VEGF or a VEGF-related ligand.
Immunogen: A synthetic peptide derived from C-terminus of human Flt-4. Epitope: C-terminus. Cellular Localization: Cytoplasmic and cell membrane. Positive Control: Placenta or breast carcinoma. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing FLT4 are readily searchable from our website. Different antibodies against the same target such as FLT4 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Bone, Brain, Embryonic Tissue, Heart, Intestine, Lung, Lymph Node, Muscle, Placenta, Vascular tissues are correlated with this protein. Anemia, Carcinoma, Congenital Abnormalities, Drug Toxicity, Edema, LYMPHEDEMA, HEREDITARY, IA, Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute, Neoplasms are some of the diseases may be linked to Flt4 (Fms-like Tyrosine Kinase 4). FLT4 also interacts with the following gene(s): FIGF, GRB2, KDR, SHC1, VEGFC.